% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Kaut:140551,
author = {Kaut, Oliver and Kuchelmeister, Klaus and Möhl, Christoph
and Wüllner, Ullrich},
title = {5-methylcytosine and 5-hydroxymethylcytosine in brains of
patients with multiple system atrophy and patients with
{P}arkinson's disease.},
journal = {Journal of chemical neuroanatomy},
volume = {96},
issn = {0891-0618},
address = {Amsterdam [u.a.]},
publisher = {Elsevier Science},
reportid = {DZNE-2020-06873},
pages = {41-48},
year = {2019},
abstract = {Multiple system atrophy (MSA) is a sporadic
neurodegenerative disorder of unknown etiology,
characterized pathologically by α-synuclein aggregates
preferentially found in oligodendroglial cells. DNA
methylation has emerged as a mechanism of regulation of
α-synuclein expression. Reduced 5-methylcytosine (5-mC) DNA
methylation of α-synuclein has been found in the brains of
patients with Parkinson's disease (PD).
5-hydroxymethylcytosine (5-hmC) methylation is another
epigenetic modification of DNA. It is involved in the
de-methylation of DNA, gene regulation, and DNA repair
mechanisms. Here, we examined sections of human
paraffin-embedded brain tissue from the cerebellum and brain
stem, including the substantia nigra pars compacta, of
patients with PD (n = 8) and MSA (n = 8) as well as
age-matched controls (n = 8). The neocortical tissue of
PD patients (n = 10) and controls (n = 10) was also
examined. Using immunohistochemistry, we analyzed the
expression of 5-mC and 5-hmC with an automatic,
rater-independent semi-quantification method. We found a
significant upregulation of 5-mC, but not 5-hmC, in cortical
sections from PD patients. The brain stem and substantia
nigra, and in particular the dopaminergic neurons, showed
unchanged levels of both 5-mC- and 5-hmC-immunoreactivity in
all groups. In the cerebellum, 5-mC was significantly
decreased only in MSA patients in the granule cell layer; in
contrast, 5-hmC was significantly upregulated in the
cerebellar white matter of both PD and MSA patients. Our
study showed different levels of expression of total 5-mC
and 5-hmC methylation across different brain regions in PD
and for the first time in MSA. Our results indicate that
5-mC may be relevant in MSA. The underlying mechanism of the
differential 5-mC and 5-hmC expression remains unclear.},
keywords = {5-Methylcytosine: analogs $\&$ derivatives /
5-Methylcytosine: analysis / 5-Methylcytosine: metabolism /
Aged / Aged, 80 and over / Brain: metabolism / Female /
Humans / Male / Middle Aged / Multiple System Atrophy:
metabolism / Parkinson Disease: metabolism},
cin = {AG Wüllner / IDAF},
ddc = {610},
cid = {I:(DE-2719)1011302 / I:(DE-2719)1040200},
pnm = {344 - Clinical and Health Care Research (POF3-344)},
pid = {G:(DE-HGF)POF3-344},
experiment = {EXP:(DE-2719)IDAF-20190308},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:30557654},
doi = {10.1016/j.jchemneu.2018.12.005},
url = {https://pub.dzne.de/record/140551},
}